Tat is an early regulatory protein of human immunodeficiency virus type 1, which plays a central role in the pathogenesis of AIDS by stimulating transcription of the viral genome and impairing several important cellular pathways during the progression of the disease. Here, we investigated the effect of Tat on cell response to DNA damage. Our results indicate that Tat production causes a noticeable increase in the survival rate of PC12 cells upon their treatment with genotoxic agents. Single-cell gel electrophoresis studies revealed reduced DNA breakage in PC12-Tat cells upon cisplatin treatment relative to the control cells. Furthermore, cytogenetic data exhibited less chromosomal damage in Tat-producing cells after recovery from cisplatin treatment, corroborating electrophoretic data. Examination of several proteins involved in the control of DNA repair showed elevated levels of Rad51, a key regulator of homologous recombination in cells expressing Tat. On the other hand, the level of Ku70, one of the components of the nonhomologous end-joining repair pathway, was slightly decreased in cells expressing Tat. Using a fluorescence-based assay, we demonstrated that repair of DNA double-strand breaks via homologous recombination is increased in Tat-producing cells. The results from in vitro nonhomologous end-joining assay revealed a reduced ability of protein extract from PC12-Tat cells compared to PC12 cells in rejoining linearized DNA. These observations ascribe a new role for Tat in host genomic integrity, perhaps by affecting the expression of genes involved in DNA repair.
Introduction
The human immunodeficiency virus type 1 (HIV-1) genome encodes several small regulatory proteins during the course of infection whose functions are beneficial for the overall replication of the viral genome and progression of the acquired immune deficiency syndrome (AIDS) (Douek et al., 2003; Lambotte et al., 2003; Persaud et al., 2003; Phimister, 2003) . One of the moststudied members of this family of proteins is Tat, which plays a pivotal role in stimulating transcription of the viral genome through a mechanism that includes its association with the viral transcript and several host basal and inducible transcription factors (Bennasser et al., 2002; Berkhout et al., 2002; Esposito et al., 2002; Reynolds et al., 2003) . In addition, Tat has been shown to alter several key host regulatory events by affecting the expression of various cytokines and immunomodulators such as TNFa, IL-2, and TGFb, which accelerate the viral infection cycle (Buonaguro et al., 1992; Chen et al., 1997; Sawaya et al., 1998; Rappaport et al., 1999; Gonzalez et al., 2001) . These events can have a drastic effect on host cells and cause a variety of morphological metabolic changes that, in some cases, steer cells toward an apoptotic pathway (McCloskey et al., 1997; Shi et al., 1998) . Of interest, some of these events may occur in uninfected cells upon their exposure to Tat secreted by infected cells (Rautonen et al., 1994; Rappaport et al., 1999) . Evidently, Tat excreted from the infected cells can be taken up by the uninfected cells and exert its regulatory activity on these recipient cells. Earlier studies have identified a role for Tat in impairing the cell cycle by altering the level of expression and/or the activity of cyclins and their associated kinases whose function orchestrates appropriate progression of cells through the cell cycle (Kundu et al., 1998; Kashanchi et al., 2000; Mahieux et al., 2001) . As other biological events in cells including DNA repair are coupled closely with the cell cycle (Lee and Kim, 2002; Brown et al., 2003; Kai and Wang, 2003) and are responsible for the maintenance of genomic integrity of the cells during the course of DNA replication or cell exposure to DNAdamaging agents, we performed experiments to assess the effect of Tat on host homologous and nonhomologous repair of the double-strand breaks induced by genotoxic agents. We used retroviral transduction to create PC12 cells expressing Tat (Peruzzi et al., 2002) . Once the production of Tat was verified in these cells by fluorescent microscopy (Figure 1a) , and its biological activity was established using transactivation of the LTR promoter (Figure 1b) , we evaluated the survival of PC12-Tat and the parental PC12 cells in response to g-irradiation and cisplatin treatment. An equal number of PC12-Tat and control PC12 cells were treated with girradiation and/or cisplatin, and after 24, 48, and 72 h, the total number of viable cells was determined. As shown in Figure 1c , in the presence of Tat, the viability of cells after exposure to cisplatin was increased in response to treatment of cells. In an alternative approach, we compared the colony-forming efficiency of PC12 and PC12-Tat cells. The sensitivity of PC12-Tat cells to cisplatin was less than that seen in PC12 cells, suggesting that the expression of Tat may facilitate the DNA repair process and/or cells expressing Tat become more resistant to DNA-damaging agents (Figure 1d ). These data corroborate the results from our recent study showing that the expression of Tat in the human astrocytic cell line, U-87MG, results in an increased viability of cells in response to DNA-damaging agents (Chipitsyna et al., unpublished data).
Next, we employed single-cell gel electrophoresis (SCGE), also known as COMET assay (Green et al., 1994; Singh et al., 1994) , to assess DNA repair by homologous recombination in the Tat-producing cells. In this assay, propidium iodide stained DNA of cells with undamaged DNA appears as well-rounded fluorescent circles, while the nuclei of cells with damaged/ unrepaired DNA appear as comets with a highly fluorescent head and a tail. The length of the comet tail and the intensity of the fluorescence of the tail correlate with the number of DNA strand breaks. Figure 1e depicts the results from SCGE in cisplatintreated PC12 and PC12-Tat cells. Each bar indicates the mean tail moment, an index that represents the length of comet tail and tail intensity (i.e. the proportion of DNA in tail) from one hundred individual cells per time point. As shown, a noticeable difference in the extent of DNA damage in PC12 compared to PC12-Tat cells was observed after 24 h of cisplatin treatment.
Should Tat facilitate the DNA repair process in PC12 cells, one would anticipate a decrease in the extent of chromosomal translocation, deletions, or loss upon the exposure of PC12-Tat cells to genotoxic agents relative to the control cells. Evaluation of chromosomal spread from PC12-Tat and PC12 cell culture at metaphase was virtually identical and showed no apparent chromosomal aberration (Figure 2 , cf top panels in a and b). However, a metaphase chromosomal spread from cisplatin-treated PC12 cells demonstrated several aberrations, including multiple chromosomal breaks, telomeric rejoining before nonhomology rejoining between the telomers of two different chromatids, a complex configuration, chromatid breaks, and refusion (Figure 2b bottom left). In contrast to these drastic chromosomal rearrangements, a metaphase chromosomal preparation from cisplatin-treated PC12-Tat cells exhibited much less chromosomal aberration and on only a few occasions was a chromosome with a chromatid gap detected (Figure 2b bottom right) . No complex configuration and frequent chromatid breaks or refusion was observed in these cells. These data suggest that PC12 cells in the presence of cisplatin manifest more severe chromosomal aberrations than the PC12-Tat cells. Detection of chromatid and chromosomal type aberrations in PC12 cells indicates that cisplatin affects DNA both before and after the S phase. Table 1 quantifies a typical chromosomal aberration in these cells. These data indicate a six-fold increase in the presence of DNA chromosomes, or a three-fold increase in chromatid gaps, and a two-fold increase in the formation of complex configuration. The absence of such damage in cisplatin-treated PC12-Tat cells suggests that Tat may provide some degree of protection, perhaps by the rapid repair of damaged DNA early and during the S period.
To elucidate the underlying mechanism involved in Tat stimulation of DNA repair and/or Tat-mediated resistance against DNA damage, we examined the levels of Rad51 and Ku70, key proteins involved in homologous recombination, and nonhomologous end-joining, respectively (Singh et al., 1994; Featherstone and Jackson, 1999; Aguilera, 2001; Venkitaraman, 2002) . Protein extracts from PC12 and PC12-Tat cells were prepared and analysed by Western blot after 24 and 48 h cisplatin treatment. As seen in Figure 3a , in PC12 cells, a slight increase in the level of Rad51 was detected at 24 h after treatment. Of interest, the level of Rad51 in PC12-Tat cells was found to be significantly higher than that in untreated (0 h) and cisplatin-treated PC12 cells after 24 and 48 h of treatment. Western blot results showed a significant increase in the levels of Ku70 in both PC12 and PC12-Tat cells after cisplatin treatment for 24 and 48 h. However, the extent of Ku70 elevation was slightly less in the Tat-producing cells in comparison to the parental Tat-negative PC12 cells. Of note, the level of Ku80 showed no significant difference in PC12 and PC12-Tat cells (data not shown). Examination of the Rad51 RNAs in PC12 and PC12 Tat cells by Northern blot indicated highest levels of Rad51 transcripts in PC12-Tat than PC12 cells, suggesting that Tat may be involved in the elevation the transcription of Rad51 in these cells (Figure 3c, top) . The level of the housekeeping gene transcript, GAPDH, served as a control for equal loading and the integrity of the RNAs in these samples (Figure 3c , bottom). To further delineate the induction of Rad51 gene transcription by Tat, PC12 as well as U-87MG cells were transfected with a plasmid construct containing a reporter gene under the control of the Rad51 promoter either alone or together with a plasmid expressing Tat protein. As seen in Figure 3d , the level of Rad51 promoter activity was increased in cells expressing Tat protein. Altogether, these observations demonstrate the ability of Tat to induce Rad51 gene expression.
The cellular localization of Rad51 in PC12 and PC12-Tat cells was examined by immunofluorescence. Consistent with the Western blot results, PC12-Tat cells appeared to contain more Rad51 than PC12 cells. A perinuclear and diffuse cytoplasmic pattern of expression for Rad51 were observed in both PC12 and PC12-Tat cells (Figure 3e ). Upon treatment of the cells with cisplatin, the perinuclear and cytoplasmic localization of Figure 1 Survival of Tat-producing PC12 cells in response to genotoxic agents. The pLEGFP-N1 retroviral vector (obtained from Clontech, CA, USA) was used to create the pLEGFP-N1-Tat expression vector by placing a cDNA fragment corresponding to the Tat gene in BglI-XhoI site. After preparation of the recombinant viral particle according to the manufacturer's instructions, PC12 cells (obtained from ATCC, Bethesda, MD, USA) were infected and cells were selected in a medium containing 0.8 mg/ml of G418 and maintained in a medium containing 0.2 mg/ml of G418. The presence of functional Tat is shown by Luciferase assay upon transfection of Tat-negative (PC12) and Tat-positive (PC12-Tat) cells with 0.5 mg of reporter LTR-Luciferase plasmid (Sawaya et al., 2000) . (c) Cell survival assay was performed by treatment of the cells with 3 mg/ml of cisplatin for 4 h. Cells were harvested at various times post-treatment and the number of viable cells was assessed by Trypan blue staining. The data represent the percent of surviving cells from three independent experiments. (d) Colony formation assay. PC12 and PC12-Tat cells were plated at 10 4 cells per 10 cm 2 dish. After 16 h, cells were treated with cisplatin (1 and 3 mg/ml). The colonogenic potential of the cells was evaluated at 27 days after treatment by counting the number of colonies after staining with methylene blue (1% in ethanol). (e) Cisplatin-induced DNA damage in PC12 and PC12-Tat cells was tested by COMET assay (Green et al., 1994; Singh et al., 1994) . Briefly, PC12 and PC12-Tat cells at various times after treatment with cisplatin (3 mg/ml) were spread on a slide precoated with 1% agarose type I-A. After solidifying, the slides were treated with lysis buffer containing 10 mM TRIS, 1% Triton X-100, 2.5 M NaCl, and 0.1 M EDTA Na 2 (pH 10.0) for 60 min at 81C, followed by a 40 min incubation in electrophoresis buffer containing 30 mM NaOH, 2 mM EDTA Na 2 (pH 12.5) for DNA unwinding. Subsequently, electrophoresis was performed for 20 min at 0.6 V/cm. For analysis, the slides were stained with 2.5 mg/ml of propidium iodide. Comets were analysed using Kinetic Imaging analysis software, Komet (v. 6, Liverpool, UK). Tail moment was used as an end point of DNA damage, which combines a measure of the length of the comet tail and the proportion of DNA to migrate into the tail. Each bar represents the mean tail moment7s.e.m. from 100 individual comets per time point HIV-1 Tat increases cell survival G Chipitsyna et al Rad51 disappeared, and Rad51 was detected as foci in the nuclei of more than 80% of both PC12 and PC12-Tat cells (Figure 3f ). Again, more Rad51 foci were observed in the nuclei of PC12-Tat than in those from PC12 cells. These observations suggest that the higher levels of Rad51 in Tat-producing cells respond appropriately to genotoxic agents and translocate to the nuclei of the affected cells to form foci at the sites of the damaged DNA.
To compare the ability of PC12 and PC12-Tat cells to repair damaged DNA, several assays were performed. First, a Luciferase-based reporter plasmid either untreated or treated with g-irradiation was introduced into PC12 and PC12-Tat cells and Luciferase activity was measured after 24 h. In comparison to PC12 cells, higher Luciferase activity was observed in PC12-Tat cells, suggesting a faster repair of the damaged transfected DNA in cells expressing Tat protein.
To further demonstrate that Tat enhances repair of double-strand DNA breaks by homologous recombination, we utilized a DR-GFP recombination assay system. This assay is based on the functional reconstruction of genes encoding green fluorescent protein, GFP, from two heteroallelic DNA fragments of GFP, which are separated by the puromycin-resistance gene in DR-GFP vector (Pierce et al., 1999) . Reconstitution of functional GFP by homologous recombination occurs upon the cleavage of DNA at the site of the SceI restriction enzyme, which is placed in one of the GFP cDNA fragments. To examine the effect of Tat on homologous recombination, a PC12 cell line stably transfected with DR-GFP was further co-transfected with a plasmid, pCbA-Sce, which expresses the SceI enzyme, alone or together with a Tat-producing plasmid. As anticipated, in the absence of the SceI expression plasmid, no GFP-positive cells were detected (Figure 4c ). In cells transfected with SceI cDNA, only 1% of the cells exhibited expression of GFP (FACS analysis), suggesting that the cells repaired, although poorly, the cleavage caused by Sce1, and that functional GFP is reconstituted in the cells (Figure 4b ). Cotransfection of the DR-GFP PC12 cells with SceI cDNA and a Tat-expressing plasmid improved the homologous recombination events, as a greater number of GFPpositive cells were observed. An increase in the amount of Tat-expressing plasmids in the transfection mixture correlates with the increase in the number of GFPpositive cells (Figure 4b ). Figure 4d and e illustrates representative microscopic results from these experiments. To further assess the fidelity of Tat-induced homologous recombination, DNA fragments corresponding to the reconstituted region of GFP cDNA were prepared from GFP-positive cells by PCR and the integrity of the rejoined DNA was verified by restriction enzyme digestion and direct sequencing.
In one approach, to test the effect of Tat on the nonhomologous end-joining process, a reporter pSC2-Luciferase plasmid DNA was treated with AvaI restriction enzyme, which cleaves the Luciferase gene at a single site. Equal amounts of linearized DNA were introduced into PC12 and PC12-Tat cells and after 24 h, Figure 2 Cytogenetic analysis of PC12-Tat cells. Tat-negative and Tat-positive PC12 cells were treated with cisplatin (1 mg/ml) for 6 h; after 24 and 48 h, 0.5 mg/ml of colcemid was added to each group. A mitotic shake-up procedure was used to collect the metaphases. The cells were hypotonized with 0.075 M KCl for 5-10 min and after fixation with methanol, acetic acid (3 : 1, v/v) for 10 min, chromosomes were spread using a standard air-dry procedure. Chromosomes were stained in 10% Giemsa for 10 min and after washing with H 2 O, mounted in Permount. Luciferase activity was determined. As shown in Figure 4f , the level of Luciferase activity was slightly lower in PC12-Tat than the control PC12 cells. In an alternative approach, we employed an in vitro assay (Baumann and West, 1998) in which protein extracts from synchronized PC12 and PC12-Tat cells at 24 and 48 h after serum stimulation were prepared and incubated with pBluescript SK ( þ /À) plasmid DNA (Stratagene, CA, USA) linearized with EcoRI restriction enzyme. After 1 h, plasmid DNAs were deproteinized and analysed by agarose gel. As seen in Figure 4g , while both PC12 and PC12-Tat cell extracts were able to rejoin the linearized DNA and form multimeric DNA bands, it was evident that the PC12 extract exhibited slightly higher end-joining activity.
Our results provide evidence for Tat-mediated improvement of the rate of homologous recombination, most probably by elevating the level of Rad51, a protein that enters the nuclei and participates in the repair process in response to DNA damage introduced during the S phase of the cell cycle. The observed enhancement in the level of Rad51 in PC12-Tat cells is not restricted In total, 0.6 mg of AvaI-cleaved pCS2-Luciferase DNA was introduced into PC12 and PC12-Tat cells and Luciferase activity was determined 24 h later. These values represent the percent of activity relative to that from the intact circular plasmid DNA (rated 100%). Reproducibility was verified through three independent experiments. (g) Protein extracts from synchronized cells at 24 and 48 h after serum stimulation were prepared according to the previously described procedure (30). A measure of 0.5 mg of pBluescript EcoRI linearized DNA was incubated with 10 mg of protein for 1 h at 371C. The reaction mixture was treated with proteinase K (Roche Molecular Biochemicals, Indianapolis, IN, USA) for 30 min at 651C prior to agarose gel electrophoresis. Lane 1 shows control cleaved DNA. M indicates marker DNAs. The arrow points to linearized DNA and the bracket depicts multimeric DNAs as a result of end-joining to the particular cell culture system that is presented here, as other cell types such as human astrocytes with Tat expression exhibit a higher level of Rad51 expression and cell viability in response to genotoxic agents (unpublished observations). According to one model, an enhanced level of Rad51 in Tat-producing cells may correlate with earlier observations on the ability of Tat to suppress p53 expression (Duan et al., 1994; Li et al., 1995; Clark et al., 2000; Magnusson et al., 2000) , an event that can lead to enhancement of homologous recombination (Sengupta et al., 2003) . Elevation of the level of Rad51 by Tat can have biological relevance and can be beneficial for HIV-1 and its lytic infection in many ways. As Rad51 has been implicated in the transcription of several cellular genes, one may speculate a role for Rad 51 on the regulation of the HIV-1 LTR.
In fact, our preliminary data suggest that cooperation of Rad51 and several transcription factors that are implicated in the regulation of the LTR results in an enhanced level of viral gene transcription (Chipitsyna et al., unpublished observations). Further, by improving DNA repair via activation of Rad 51, Tat may decrease the occurrence of deleterious mutations in the critical region of the integrated proviral DNA during the course of cellular DNA replication. By maintaining the integrity of the cellular genome during the course of cell division, Tat may minimize cellular events that may not be suitable for viral replication. Thus, one can envision a dual role for Tat in stimulating viral gene expression during the course of infection; the direct effect that includes transcriptional activation of the HIV-1 genome through regions spanning the viral LTR (Liang and Wainberg, 2002) , and an indirect effect by maintaining or improving host regulatory events that could be beneficial for viral replication. The indirect effect may be mediated by alteration of cellular gene expression, which in turn increases the efficiency of viral replication and further contributes to the pathogenesis of disease. For instance, upregulation of TNFa by Tat can lead to the induction of NF-kB pathways and its subunits p50/p65, all of which are important for transcription of the viral genome and activation of several cellular pathways (Barboric et al., 2001) . Here, we describe an unusual function for Tat that relates to the ability of the viral protein to assist in the maintenance of host cells' genetic integrity. This event can extend cell survival and thus provides extra opportunity for HIV-1 to complete fully its infectious cycle. We also unraveled the ability of Tat to decrease, although slightly, the level of Ku70 and minimally affect the process of nonhomologous end-joining. While the importance of this event in HIV-1 interaction with the host remains to be evaluated, these observations indicate that Tat may have a diverse effect on various parameters involved in the maintenance of the integrity of the host genome. These new findings on the biological activity of Tat can be utilized to better understand the pathogenesis of AIDS, particularly under those conditions where HIV-1 infection is associated with cancers such as B cell lymphoma and Kaposi's sarcoma. Further, these observations can provide a new avenue of investigation on the role of Tat in neuronal cell function and its behavior in response to DNA mismatch and repair.
